Home > PE Ratio > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of JAGSONPAL PHARMACEUTICALS is 30.02.

Share Price ₹279.9Mar 28,2024
Market Cap ₹736.0 Cr
Earnings-TTM₹24.5 CrTTM-Standalone Results
Price/Earnings30.02xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for JAGSONPAL PHARMACEUTICALS
Please provide your vote to see the results
JAGSONPAL PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PE (Price/Earnings) ratio of JAGSONPAL PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of JAGSONPAL PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹736.0 Cr] as on Mar 28,2024

(/) Earnings [ ₹24.5 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 30.02x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for JAGSONPAL PHARMACEUTICALS , the investors are currently willing to pay 30.02 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of JAGSONPAL PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of JAGSONPAL PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of JAGSONPAL PHARMACEUTICALS


PE Ratio Performance Analysis for JAGSONPAL PHARMACEUTICALS

- JAGSONPAL PHARMACEUTICALS 's latest p/e ratio is 30.02x.

- JAGSONPAL PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 19.91x.

- JAGSONPAL PHARMACEUTICALS 's operated at median p/e ratio of 12.22x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, JAGSONPAL PHARMACEUTICALS 's p/e ratio peaked in Mar2022 at 43.57x.

- JAGSONPAL PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 5.81x.


How does JAGSONPAL PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
JAGSONPAL PHARMACEUTICALS 24.5230.02736.0
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6343.21388,812.0
CIPLA LTD3,744.0332.23120,673.0
DR REDDYS LABORATORIES LTD5,209.4019.71102,679.0
ZYDUS LIFESCIENCES LTD2,954.2034.24101,152.0
DIVIS LABORATORIES LTD1,382.9765.9791,234.9
MANKIND PHARMA LTD1,743.3052.7992,029.2
TORRENT PHARMACEUTICALS LTD1,494.0058.9388,034.7
LUPIN LTD1,809.7440.7473,722.0
AUROBINDO PHARMA LTD2,777.8922.9863,835.1
ABBOTT INDIA LTD1,145.5849.9857,258.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs JAGSONPAL PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.71x
Max industry PE 65.97x
Median industry PE 40.74x
Average industry PE 40.98x



You may also like the below Video Courses